Logo image of BLMN

BLOOMIN' BRANDS INC (BLMN) Stock Fundamental Analysis

USA - NASDAQ:BLMN - US0942351083 - Common Stock

7.02 USD
+0.13 (+1.89%)
Last: 11/5/2025, 1:24:03 PM
Fundamental Rating

3

Overall BLMN gets a fundamental rating of 3 out of 10. We evaluated BLMN against 132 industry peers in the Hotels, Restaurants & Leisure industry. While BLMN is still in line with the averages on profitability rating, there are concerns on its financial health. BLMN has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BLMN was profitable.
BLMN had a positive operating cash flow in the past year.
In multiple years BLMN reported negative net income over the last 5 years.
BLMN had a positive operating cash flow in each of the past 5 years.
BLMN Yearly Net Income VS EBIT VS OCF VS FCFBLMN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

BLMN's Return On Assets of -0.15% is on the low side compared to the rest of the industry. BLMN is outperformed by 65.91% of its industry peers.
With a Return On Equity value of -1.25%, BLMN perfoms like the industry average, outperforming 49.24% of the companies in the same industry.
BLMN has a Return On Invested Capital of 4.48%. This is comparable to the rest of the industry: BLMN outperforms 47.73% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BLMN is in line with the industry average of 10.76%.
The last Return On Invested Capital (4.48%) for BLMN is well below the 3 year average (9.55%), which needs to be investigated, but indicates that BLMN had better years and this may not be a problem.
Industry RankSector Rank
ROA -0.15%
ROE -1.25%
ROIC 4.48%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
BLMN Yearly ROA, ROE, ROICBLMN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

1.3 Margins

With a Operating Margin value of 3.89%, BLMN is not doing good in the industry: 69.70% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of BLMN has grown nicely.
The Gross Margin of BLMN (71.11%) is better than 86.36% of its industry peers.
BLMN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 3.89%
PM (TTM) N/A
GM 71.11%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
BLMN Yearly Profit, Operating, Gross MarginsBLMN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BLMN is creating some value.
The number of shares outstanding for BLMN has been reduced compared to 1 year ago.
The number of shares outstanding for BLMN has been reduced compared to 5 years ago.
BLMN has a worse debt/assets ratio than last year.
BLMN Yearly Shares OutstandingBLMN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BLMN Yearly Total Debt VS Total AssetsBLMN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BLMN has an Altman-Z score of 0.85. This is a bad value and indicates that BLMN is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BLMN (0.85) is worse than 68.94% of its industry peers.
BLMN has a debt to FCF ratio of 15.15. This is a negative value and a sign of low solvency as BLMN would need 15.15 years to pay back of all of its debts.
BLMN has a Debt to FCF ratio of 15.15. This is comparable to the rest of the industry: BLMN outperforms 47.73% of its industry peers.
BLMN has a Debt/Equity ratio of 2.34. This is a high value indicating a heavy dependency on external financing.
BLMN has a Debt to Equity ratio (2.34) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF 15.15
Altman-Z 0.85
ROIC/WACC0.56
WACC8.06%
BLMN Yearly LT Debt VS Equity VS FCFBLMN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 0.43 indicates that BLMN may have some problems paying its short term obligations.
BLMN has a Current ratio of 0.43. This is amonst the worse of the industry: BLMN underperforms 81.82% of its industry peers.
BLMN has a Quick Ratio of 0.43. This is a bad value and indicates that BLMN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.35, BLMN is doing worse than 79.55% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.43
Quick Ratio 0.35
BLMN Yearly Current Assets VS Current LiabilitesBLMN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

0

3. Growth

3.1 Past

The earnings per share for BLMN have decreased strongly by -37.08% in the last year.
The Earnings Per Share has been growing slightly by 3.30% on average over the past years.
The Revenue for BLMN has decreased by -19.61% in the past year. This is quite bad
BLMN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.93% yearly.
EPS 1Y (TTM)-37.08%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-35.29%
Revenue 1Y (TTM)-19.61%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-10.41%

3.2 Future

The Earnings Per Share is expected to decrease by -12.06% on average over the next years. This is quite bad
BLMN is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.00% yearly.
EPS Next Y-40.88%
EPS Next 2Y-21.96%
EPS Next 3Y-12.06%
EPS Next 5YN/A
Revenue Next Year-11.35%
Revenue Next 2Y-5.19%
Revenue Next 3Y-3%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BLMN Yearly Revenue VS EstimatesBLMN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
BLMN Yearly EPS VS EstimatesBLMN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2

7

4. Valuation

4.1 Price/Earnings Ratio

BLMN is valuated cheaply with a Price/Earnings ratio of 4.65.
Based on the Price/Earnings ratio, BLMN is valued cheaper than 97.73% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.03. BLMN is valued rather cheaply when compared to this.
BLMN is valuated cheaply with a Price/Forward Earnings ratio of 6.40.
BLMN's Price/Forward Earnings ratio is rather cheap when compared to the industry. BLMN is cheaper than 96.21% of the companies in the same industry.
BLMN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.27.
Industry RankSector Rank
PE 4.65
Fwd PE 6.4
BLMN Price Earnings VS Forward Price EarningsBLMN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

BLMN's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BLMN is cheaper than 90.91% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BLMN is valued cheaper than 92.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.7
EV/EBITDA 4.76
BLMN Per share dataBLMN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

A cheap valuation may be justified as BLMN's earnings are expected to decrease with -12.06% in the coming years.
PEG (NY)N/A
PEG (5Y)1.41
EPS Next 2Y-21.96%
EPS Next 3Y-12.06%

6

5. Dividend

5.1 Amount

BLMN has a Yearly Dividend Yield of 8.66%, which is a nice return.
BLMN's Dividend Yield is rather good when compared to the industry average which is at 4.11. BLMN pays more dividend than 97.73% of the companies in the same industry.
BLMN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 8.66%

5.2 History

On average, the dividend of BLMN grows each year by 19.12%, which is quite nice.
BLMN has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of BLMN decreased in the last 3 years.
Dividend Growth(5Y)19.12%
Div Incr Years0
Div Non Decr Years2
BLMN Yearly Dividends per shareBLMN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of BLMN are negative and hence is the payout ratio. BLMN will probably not be able to sustain this dividend level.
DP-1330.72%
EPS Next 2Y-21.96%
EPS Next 3Y-12.06%
BLMN Yearly Income VS Free CF VS DividendBLMN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

BLOOMIN' BRANDS INC

NASDAQ:BLMN (11/5/2025, 1:24:03 PM)

7.02

+0.13 (+1.89%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-06 2025-11-06/bmo
Inst Owners107.41%
Inst Owner Change0.2%
Ins Owners1.63%
Ins Owner Change2.81%
Market Cap597.19M
Revenue(TTM)3.69B
Net Income(TTM)-4978000
Analysts54.44
Price Target7.88 (12.25%)
Short Float %11.28%
Short Ratio4.4
Dividend
Industry RankSector Rank
Dividend Yield 8.66%
Yearly Dividend0.96
Dividend Growth(5Y)19.12%
DP-1330.72%
Div Incr Years0
Div Non Decr Years2
Ex-Date08-19 2025-08-19 (0.15)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.74%
Min EPS beat(2)3.69%
Max EPS beat(2)13.79%
EPS beat(4)4
Avg EPS beat(4)5.28%
Min EPS beat(4)0.68%
Max EPS beat(4)13.79%
EPS beat(8)6
Avg EPS beat(8)1.3%
EPS beat(12)10
Avg EPS beat(12)3.14%
EPS beat(16)13
Avg EPS beat(16)4%
Revenue beat(2)0
Avg Revenue beat(2)-0.19%
Min Revenue beat(2)-0.32%
Max Revenue beat(2)-0.06%
Revenue beat(4)0
Avg Revenue beat(4)-0.83%
Min Revenue beat(4)-2.28%
Max Revenue beat(4)-0.06%
Revenue beat(8)0
Avg Revenue beat(8)-1.59%
Revenue beat(12)1
Avg Revenue beat(12)-1.69%
Revenue beat(16)2
Avg Revenue beat(16)-1.69%
PT rev (1m)2.43%
PT rev (3m)-13.02%
EPS NQ rev (1m)-1.61%
EPS NQ rev (3m)-341.61%
EPS NY rev (1m)-0.58%
EPS NY rev (3m)-13.75%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.43%
Valuation
Industry RankSector Rank
PE 4.65
Fwd PE 6.4
P/S 0.16
P/FCF 9.7
P/OCF 2.54
P/B 1.5
P/tB N/A
EV/EBITDA 4.76
EPS(TTM)1.51
EY21.51%
EPS(NY)1.1
Fwd EY15.62%
FCF(TTM)0.72
FCFY10.3%
OCF(TTM)2.76
OCFY39.36%
SpS43.36
BVpS4.67
TBVpS-3.12
PEG (NY)N/A
PEG (5Y)1.41
Graham Number12.6
Profitability
Industry RankSector Rank
ROA -0.15%
ROE -1.25%
ROCE 5.66%
ROIC 4.48%
ROICexc 4.57%
ROICexgc 6.23%
OM 3.89%
PM (TTM) N/A
GM 71.11%
FCFM 1.67%
ROA(3y)2.17%
ROA(5y)1.65%
ROE(3y)1.18%
ROE(5y)-770.59%
ROIC(3y)9.55%
ROIC(5y)N/A
ROICexc(3y)9.93%
ROICexc(5y)N/A
ROICexgc(3y)14.52%
ROICexgc(5y)N/A
ROCE(3y)12.09%
ROCE(5y)N/A
ROICexgc growth 3Y-22.65%
ROICexgc growth 5Y1.95%
ROICexc growth 3Y-20.61%
ROICexc growth 5Y2.37%
OM growth 3Y-17.82%
OM growth 5Y1.66%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.36%
GM growth 5Y0.51%
F-Score6
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 2.34
Debt/FCF 15.15
Debt/EBITDA 3.01
Cap/Depr 104.97%
Cap/Sales 4.7%
Interest Coverage 2.42
Cash Conversion 76.16%
Profit Quality N/A
Current Ratio 0.43
Quick Ratio 0.35
Altman-Z 0.85
F-Score6
WACC8.06%
ROIC/WACC0.56
Cap/Depr(3y)141.63%
Cap/Depr(5y)109.75%
Cap/Sales(3y)6.11%
Cap/Sales(5y)4.82%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.08%
EPS 3Y-12.64%
EPS 5Y3.3%
EPS Q2Q%-35.29%
EPS Next Y-40.88%
EPS Next 2Y-21.96%
EPS Next 3Y-12.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-19.61%
Revenue growth 3Y-1.41%
Revenue growth 5Y-0.93%
Sales Q2Q%-10.41%
Revenue Next Year-11.35%
Revenue Next 2Y-5.19%
Revenue Next 3Y-3%
Revenue Next 5YN/A
EBIT growth 1Y-52.2%
EBIT growth 3Y-18.98%
EBIT growth 5Y0.71%
EBIT Next Year20.5%
EBIT Next 3Y9.67%
EBIT Next 5YN/A
FCF growth 1Y-64.71%
FCF growth 3Y-70.21%
FCF growth 5Y-45.63%
OCF growth 1Y-48.83%
OCF growth 3Y-17.24%
OCF growth 5Y-6.4%

BLOOMIN' BRANDS INC / BLMN FAQ

What is the ChartMill fundamental rating of BLOOMIN' BRANDS INC (BLMN) stock?

ChartMill assigns a fundamental rating of 3 / 10 to BLMN.


What is the valuation status for BLMN stock?

ChartMill assigns a valuation rating of 7 / 10 to BLOOMIN' BRANDS INC (BLMN). This can be considered as Undervalued.


How profitable is BLOOMIN' BRANDS INC (BLMN) stock?

BLOOMIN' BRANDS INC (BLMN) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for BLMN stock?

The Price/Earnings (PE) ratio for BLOOMIN' BRANDS INC (BLMN) is 4.65 and the Price/Book (PB) ratio is 1.5.


What is the financial health of BLOOMIN' BRANDS INC (BLMN) stock?

The financial health rating of BLOOMIN' BRANDS INC (BLMN) is 2 / 10.